The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
about
Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitinationProtein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3FBXO44-Mediated Degradation of RGS2 Protein Uniquely Depends on a Cullin 4B/DDB1 Complex.The role of the unfolded protein response in the heart.Insights into the regulation of intrinsically disordered proteins in the human proteome by analyzing sequence and gene expression data.Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy.The ubiquitin proteasome system in human cardiomyopathies and heart failure.Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps.The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2).Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis.Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor.Exercise training restores cardiac protein quality control in heart failure.Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.NF-κB inhibition protects against tumor-induced cardiac atrophy in vivo.Proteome dynamics and proteome function of cardiac 19S proteasomesUbiquitin carboxyl terminal hydrolyase L1-suppressed autophagic degradation of p21WAF1/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferationInsulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function.Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophyIn search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceUnraveling the complexity of ubiquitin signalingSodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.Primary proteasome inhibition results in cardiac dysfunctionHECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription.Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heart.Protein quality control and degradation in cardiomyocytes.A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome.Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy.Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T MutationsThe E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1α and Pink1.Maintenance of muscle mass and load-induced growth in Muscle RING Finger 1 null mice with age.Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database.Molecular- and organelle-based predictive paradigm underlying recovery by left ventricular assist device support.Mechanisms and management of doxorubicin cardiotoxicity.Proteasome dysfunction in cardiomyopathies.Post-infarct sleep disruption and its relation to cardiac remodeling in a rat model of myocardial infarction.Target acquired: Selective autophagy in cardiometabolic disease.Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.
P2860
Q28116438-67D02900-27DB-408F-AF08-6BFA729D26FFQ28730834-DDCA40F6-CADA-49BE-A90D-4AAEAE026738Q30176404-9172B08C-04DD-4940-AB20-46AA40EFFE53Q30366262-59A96CEE-07C7-4179-B037-C96496421754Q33443462-8EB89826-4BAB-414A-AB64-9382A16CCCADQ33679929-37315BAB-00A4-45E2-9BDB-A4AA125C9AD5Q33699632-9A411B6B-44B4-4482-A325-32D7DD872147Q33816688-DE722BDC-75E8-49F9-933C-832BAD529BEFQ33887660-0C20538F-E3CB-419E-9D54-3C4284B4F5B9Q33919062-143084C4-90A7-436E-8C2E-BB2190FDD18BQ34016246-E23AD6C2-111A-4279-8000-4F8ED42C3CB7Q34352826-9CA2C324-0967-4BEA-8FEC-36A90BB37060Q34541132-DDD76912-567A-4E92-97B8-61FD5014EB87Q34592321-A79588F6-C773-423C-8BB9-34F534DDA1A6Q34760711-F0026A09-3376-4B0F-921C-DED6DCE981BDQ34994354-740039D5-9BCC-41D4-9AC4-DF4A760979CCQ35147643-815AB94D-5FEB-43F2-92EC-C3FF837FDB77Q35783723-A7438D74-223B-429C-96EC-74EE972A81FFQ35990041-7B7E6623-AE24-45A2-9951-E89661AA75FDQ36364300-FC0E88C6-B1CD-40EF-B521-E10711A8E5AEQ36722909-9D82AC5E-1714-4DE1-9E7E-9069561A1306Q36784081-D58A4672-BB1D-4131-B3B8-0B172456D74BQ36865776-12699DDA-E94F-4C47-BA9C-9415D4FDE1F3Q36877602-53E4D687-6314-41BC-9F32-F2D200FBF5CAQ36893284-7E710093-319C-4373-9C61-2C9961F7CCECQ36897605-027B35D4-C271-4AE7-90B6-5A715F1763CAQ36952213-819BC70E-AEB3-482F-9C4A-8A560B96FAF6Q37124125-52877A69-A6AF-4937-A569-D97CD67B0381Q37263689-763F4067-9B14-43BC-939B-A3C1E1A8D72CQ37275558-376F93BE-246A-4731-B180-3AA0CC31C811Q37372239-EDC2C7A1-6CAF-409E-A10D-C4C8005336DBQ37620424-90FAC7CD-3D99-488F-91F0-605846A0EB47Q37625578-3DD15C1E-DD04-4B90-9C87-CC48A0E7265FQ38115568-0EBC1655-EEF8-4FBC-8BD4-FF9478857489Q38197123-5CEB78C2-58FC-498B-A81D-36214F7C41E4Q38473474-2A53A49E-9777-4A9B-B191-F402E022FC05Q38970493-9FF299AC-C277-4D4D-9BB3-F0669F148641Q38982144-F73EB541-18E5-47B1-A5EE-4BD8C5EAFD26Q39155198-4AFAA280-AAF7-4D85-A6ED-C2A8EDA1BC6EQ40367733-209FD7CC-8079-473A-8B16-88C522292755
P2860
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
@ast
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
@en
type
label
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
@ast
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
@en
prefLabel
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
@ast
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
@en
P2093
P1433
P1476
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
@en
P2093
Cam Patterson
Christopher Ike
George A Stouffer
Monte S Willis
Park W Willis
P304
P356
10.1161/CIRCULATIONAHA.106.649863
P407
P577
2007-03-01T00:00:00Z